Whalen Wealth Management Inc. Takes Position in Merit Medical Systems, Inc. $MMSI

Whalen Wealth Management Inc. acquired a new position in Merit Medical Systems, Inc. (NASDAQ:MMSI) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 8,238 shares of the medical instruments supplier’s stock, valued at approximately $571,000.

Other institutional investors and hedge funds also recently bought and sold shares of the company. AQR Capital Management LLC boosted its holdings in shares of Merit Medical Systems by 7.3% during the first quarter. AQR Capital Management LLC now owns 16,361 shares of the medical instruments supplier’s stock worth $1,730,000 after purchasing an additional 1,114 shares during the period. Goldman Sachs Group Inc. increased its stake in Merit Medical Systems by 16.9% in the 1st quarter. Goldman Sachs Group Inc. now owns 719,313 shares of the medical instruments supplier’s stock valued at $76,039,000 after buying an additional 103,878 shares during the period. EverSource Wealth Advisors LLC lifted its position in Merit Medical Systems by 745.9% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 922 shares of the medical instruments supplier’s stock worth $86,000 after buying an additional 813 shares in the last quarter. First Trust Advisors LP boosted its stake in shares of Merit Medical Systems by 24.8% during the 2nd quarter. First Trust Advisors LP now owns 59,215 shares of the medical instruments supplier’s stock valued at $5,535,000 after buying an additional 11,770 shares during the period. Finally, Cerity Partners LLC grew its holdings in shares of Merit Medical Systems by 9.1% during the 2nd quarter. Cerity Partners LLC now owns 3,019 shares of the medical instruments supplier’s stock valued at $282,000 after acquiring an additional 251 shares in the last quarter. Hedge funds and other institutional investors own 99.66% of the company’s stock.

Analyst Ratings Changes

Several analysts recently issued reports on the company. Needham & Company LLC increased their price objective on Merit Medical Systems from $90.00 to $101.00 and gave the stock a “buy” rating in a report on Friday, July 31st. Raymond James Financial reaffirmed an “outperform” rating and set a $100.00 price target on shares of Merit Medical Systems in a research note on Friday, July 31st. Weiss Ratings upgraded Merit Medical Systems from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, August 18th. JPMorgan Chase & Co. boosted their price target on Merit Medical Systems from $77.00 to $95.00 and gave the company an “overweight” rating in a research note on Friday, July 31st. Finally, BTIG Research restated a “buy” rating and issued a $105.00 price objective on shares of Merit Medical Systems in a report on Tuesday, August 11th. Eight analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $100.00.

Merit Medical Systems Stock Down 0.6%

Shares of Merit Medical Systems stock opened at $90.28 on Tuesday. Merit Medical Systems, Inc. has a 12-month low of $59.74 and a 12-month high of $94.75. The stock has a market capitalization of $5.39 billion, a P/E ratio of 37.31, a PEG ratio of 2.28 and a beta of 0.48. The company has a quick ratio of 2.79, a current ratio of 4.20 and a debt-to-equity ratio of 0.44. The stock has a 50 day moving average price of $77.88 and a two-hundred day moving average price of $72.58.

Merit Medical Systems (NASDAQ:MMSI) last issued its quarterly earnings data on Thursday, July 30th. The medical instruments supplier reported $1.19 earnings per share for the quarter, topping analysts’ consensus estimates of $0.96 by $0.23. Merit Medical Systems had a net margin of 9.22% and a return on equity of 13.75%. The business had revenue of $418.84 million during the quarter, compared to analysts’ expectations of $405.25 million. During the same period in the previous year, the company earned $1.01 earnings per share. Merit Medical Systems’s revenue for the quarter was up 9.5% on a year-over-year basis. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. Equities analysts expect that Merit Medical Systems, Inc. will post 3.81 earnings per share for the current year.

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.